One of the biggest challenges in cancer therapy is being able to sufficiently deliver chemotherapy drugs to tumors without exposing healthy tissues to their toxic effects
A new tumor-modeling platform called a tumor-microenvironment-on-chip can be used to visualize and quantify how different types of cancer cells react differently to the chemotherapy drug doxorubicin